News

Syn Bio Beta
synbiobeta. com > read > liliana-nordbakk-on-building-ai-native-biology-companies

Liliana Nordbakk on Building AI-Native Biology Companies

1+ day, 15+ hour ago  (224+ words) "My route was through Silicon Valley entrepreneurship and investing," Nordbakk said. "What clicked for me was the 'software of life' lens. If the genome is code, with syntax, grammar, and execution rules, then we can read, simulate, and program cellular…...

Syn Bio Beta
synbiobeta. com > read > herasight-develops-genetic-tests-for-embryos-that-can-reduce-disease-and-boost-iq

Herasight Develops Genetic Tests for Embryos That Can Reduce Disease and Boost IQ

1+ day, 15+ hour ago  (539+ words) In an exclusive conversation ahead of Syn Bio Beta 2026, Jonathan Anomaly frames the discussion around a simple reality: parents are already making choices that influence their children's genes when they select a mate. In many cases, those decisions are becoming…...

Syn Bio Beta
synbiobeta. com > read > opening-the-biological-black-box-with-krish-ramadurai

Opening the Biological Black Box with Krish Ramadurai

1+ day, 15+ hour ago  (227+ words) In an exclusive conversation ahead of his appearance at Syn Bio Beta 2026 on May 47 in San Jose, Krish Ramadurai, Partner at AIX Ventures and Oxford-trained biomolecular engineer, frames the problem directly. DNA can now be written and designed with remarkable…...

Syn Bio Beta
synbiobeta. com > read > evolution-built-the-perfect-bioreactor-neion-bio-is-finally-using-it

Evolution Built the Perfect Bioreactor. Neion Bio Is Finally Using It.

4+ day, 11+ hour ago  (231+ words) In an exclusive conversation ahead of their appearance at Syn Bio Beta 2026 on May 47th in San Jose, Neion Bio co-founder and CTO Sam Levin, an evolutionary biologist turned entrepreneur, makes the case that the future of drug manufacturing has been…...

Syn Bio Beta
synbiobeta. com > read > jamie-bacher-on-the-one-obstacle-synthetic-biology-must-finally-solve

Jamie Bacher on the One Obstacle Synthetic Biology Must Finally Solve

1+ week, 13+ hour ago  (287+ words) In an exclusive conversation ahead of his panel appearance at Syn Bio Beta in May, biomanufacturing veteran Jamie Bacher is blunt about what's holding synthetic biology back: time to market. Bacher's newest company, Finish Line Bio, is built around that…...

synbiobeta. com
synbiobeta. com > read > lowering-the-barriers-to-biotech-how-douglas-crawford-built-an-engine-for-scientific-entrepreneurs

Lowering the Barriers to Biotech: How Douglas Crawford Built an Engine for Scientific Entrepreneurs

1+ week, 1+ day ago  (794+ words) In an exclusive conversation ahead of his appearance at Syn Bio Beta 2026 on May 47 in San Jose, Douglas Crawford describes a career defined by a single, consistent mission. "I have been singularly focused on helping scientific entrepreneurs turn their promising…...

Syn Bio Beta
synbiobeta. com > read > inside-10x-genomics%E2%80%99-mission-to-measure-biology-at-scale

Inside 10x Genomics" Mission to Measure Biology at Scale

1+ week, 6+ day ago  (702+ words) As single-cell and spatial technologies generate unprecedented biological datasets, 10x Genomics is positioning itself at the center of the emerging "hyperscale biology" era. We still don't understand most of biology because it's hard to measure. The molecular machinery of life operates…...

Syn Bio Beta
synbiobeta. com > read > breakout-ventures-launches-114m-fund-iii-to-double-down-on-deep-tech

Breakout Ventures Launches $114 M Fund III to Double Down on Deep Tech

4+ week, 1+ day ago  (277+ words) From Breakout Labs to a $114 million third fund, Breakout Ventures has spent a decade proving that deep-tech venture investing delivers. Their portfolio spans AI-powered diagnostics, sustainable aviation fuel, neural interfaces, and fossil-free materials " with real exits and partnerships to show…...

Syn Bio Beta
synbiobeta. com > read > centivax-doses-first-participants-in-phase-1-trial-of-universal-flu-vaccine

Centivax Doses First Participants in Phase 1 Trial of Universal Flu Vaccine

1+ mon, 3+ week ago  (356+ words) South San Francisco, Calif. " Feb. 12, 2026 Centivax has dosed the first participants in a Phase 1 A clinical trial of Centi-Flu 01, its pan-influenza universal flu vaccine candidate, marking the company's transition into clinical-stage development. The randomized, double-blind, placebo-controlled dose-escalation study will evaluate…...

Syn Bio Beta
synbiobeta. com > read > why-the-department-of-war-is-backing-visolis-to-scale-bio-based-solvents

Why the Department of War Is Backing Visolis to Scale Bio-Based Solvents

2+ mon, 9+ hour ago  (277+ words) While much of synthetic biology has focused on high-margin products, Visolis is building its business in factories, refineries, and maintenance depots that underpin modern infrastructure. The company is demonstrating that biology's greatest impact may come from displacing petroleum for fuels,…...